Volume 18, Number 3—March 2012
CME ACTIVITY - Research
Community-associated Clostridium difficile Infections, Monroe County, New York, USA
Table 2
Characteristic | HCFO | CO-HCA | CA† | p value |
---|---|---|---|---|
Complications | ||||
Hospitalized for CDI | NC | 39 (38) | 13 (19) | 0.02 |
Median length of stay, d (SD) | NC | 7 (17) | 4 (11) | 0.06 |
Outcome‡ | ||||
Survived | 158 (80) | 89 (86) | 44 (66) | ND |
Died | 23 (12) | 9 (9) | 0 (0) | ND |
Unknown | 15 (8) | 5 (5) | 23 (34) | ND |
Deaths caused by CDI | ||||
Yes | 7/23 (30) | 3/9 (33) | NC | ND |
No | 3/23(13) | 3/9 (33) | NC | ND |
Unknown | 13/23 (57) | 3/9 (33) | NC | ND |
Laboratory-confirmed recurrence (>1) | 43 (22) | 23 (22) | 8 (12) | 0.17 |
*Values are no. (%) positive or no. positive/no. tested (%) except as indicated. CDI, Clostridium difficile infection; HCFO, health care facility onset; CO-HCA, community onset–health care associated; CA, community associated; NC, not compared, ND, not determined.
†Definite and probable CA cases.
‡For hospitalized patients, death occurred in the hospital. For nonhospitalized patients, death occurred 8 weeks after a positive C. difficile assay result.
Page created: February 23, 2012
Page updated: February 23, 2012
Page reviewed: February 23, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.